Limoneira (LMNR) has kicked off Q1 2026 with revenue of US$18.2 million and a basic EPS loss of US$0.53, alongside a trailing twelve month EPS loss of US$1.28 on revenue of US$143.6 million, setting a cautious tone around profitability. The company has seen quarterly revenue move from US$34.3 million in Q1 2025 to US$18.2 million in Q1 2026, while basic EPS shifted from a loss of US$0.18 to a loss of US$0.53, putting the focus squarely on how efficiently each dollar of sales is translating into bottom line results. Against that backdrop, investors are likely to concentrate on where margins can stabilize or recover from here as the latest numbers feed into longer term expectations.

See our full analysis for Limoneira.

With the raw figures on the table, the next step is to see how these results line up with the prevailing stories around Limoneira, highlighting where the numbers back up the narratives and where they start to pull in a different direction.

Losses widen with US$22.9 million trailing net loss

• On a trailing twelve month basis, Limoneira recorded a net loss of US$22.9 million on revenue of US$143.6 million, compared with a trailing loss of US$16.5 million on US$159.7 million of revenue at the end of Q4 2025. Recent quarters have added to cumulative losses while the top line has been lower than a year ago, when revenue was US$191.5 million and net income was US$7.1 million.
• Consensus narrative discusses profit margins moving from roughly a 1.3% loss today to a 6.0% margin in three years. However, the current trailing loss of US$22.9 million and basic EPS of US$1.28 in losses highlight how far results are from the analysts' case that earnings could reach US$7.3 million by 2028. Anyone leaning on that view needs to weigh it against the recent step from a US$7.6 million profit in early 2025 to the present loss position.

Valuation sits between peers and DCF fair value

• At a share price of US$13.20 and a trailing P/S of 1.6x, Limoneira trades below the cited peer average of 3.2x but above the US Food industry average of 0.7x. That market price is also above the DCF fair value reference of US$5.93, which indicates that investors are paying a higher multiple than that discounted cash flow figure, even while revenue over the last year stands at US$143.6 million and earnings are still in loss.
• Bulls point to potential earnings of US$8.7 million and EPS of US$0.47 by 2028. The fact that the current price of US$13.20 implies a higher level than the US$5.93 DCF fair value and already sits on a 1.6x P/S, while the latest twelve month loss is US$22.9 million, means the bullish idea of paying a high future P/E multiple has to be set against today’s mix of losses and a valuation that is not low compared with the broader US Food industry.

If you want to see how supporters of the optimistic case are connecting these numbers to future EPS targets, check out the latest bull case summary for Limoneira here: 🐂 Limoneira Bull Case

Dividend coverage tension with ongoing losses

• The trailing dividend yield of 2.18% is described as not well covered by earnings or free cash flow. This aligns with the recent pattern of a trailing twelve month net loss of US$22.9 million and basic EPS losses in every reported quarter back to Q4 2024, including a loss of US$0.53 per share in Q1 2026 and US$0.49 per share in Q4 2025.
• Bears argue that ongoing losses, exposure to lemon and avocado pricing, and higher net debt could strain Limoneira’s ability to maintain payouts. The combination of a 2.18% yield with trailing net income that moved from a US$7.1 million profit a year ago to US$22.9 million in losses today, plus quarterly net losses ranging from US$0.996 million to US$9.6 million, gives that cautious view some numerical backing around the dividend and balance sheet risk.

For a closer look at how skeptics are reading these payout and balance sheet pressures, you can walk through the full bear case on Limoneira here: 🐻 Limoneira Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Limoneira on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of risks and potential rewards feels finely balanced, it is a good time to look through the numbers yourself and move quickly in forming your own view, starting with 1 key reward and 1 important warning sign.

See What Else Is Out There

Limoneira is contending with widening losses, a P/S above the US Food industry average, and dividend coverage concerns that keep pressure on both profitability and the balance sheet.

If those issues have you questioning the risk side of your portfolio, use 69 resilient stocks with low risk scores to quickly focus on companies with more resilient profiles right now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.